Will the AACR Annual Meeting 2026 feature an official press release announcing a combination immunotherapy trial result with progression-free survival improvement of more than 4 months compared to monotherapy in any cancer type, announced by April 22, 2026?

An AACR press release published between April 20–22, 2026 describes a combination immunotherapy trial where median progression-free survival improvement exceeds 4 months compared to the monotherapy control arm Source: AACR official press releases at aacr.org/meeting/aacr-annual-meeting-2026/press-releases/